Story image

Kiwi AI breast cancer detection solution raises $AU20 million

05 Jun 2018

Wellington-based ASX-listed Volpara Health Technologies has raised $AU20 million through an oversubscribed placement to institutional investors and a share purchase plan to speed up growth in the US, expand New Zealand research and development (R&D) and fund the rollout of direct sales into Asia.

This announcement from Volpara, which focuses on early detection of breast cancer using artificial intelligence, comes alongside releasing strong results for the full financial year March 2018.

Volpara CEO Dr Ralph Highnam says the company has delivered year-on-year growth as a result of its successful transition, begun in FY17, from a predominantly capital sales model to a Software as a Service (SaaS) model.

“These results reflect progress made in FY18, where we met all our objectives, including increasing annualised recurring revenue by more than 200%, while keeping costs mostly in line with FY17 and increasing our market share to more than 3% of US women.

“It is pleasing to see our progress now beginning to be reflected in the financial results we are delivering.”

Cash on hand was NZ$4.84m as at 31 March 2018, and now is approximately NZ$24.5m after the successful placement and share purchase plan raising A$20m for the company.

“We have continued to develop VolparaEnterprise throughout FY18 while also making advances in our product pipeline, with some exciting new products set to be released by the Wellington-based engineering team to the market towards the end of the calendar year,” Highnam says.

“These products will help to ensure we have happy customers and at the same time draw more customers in and increase price per woman.

“With the capital raise, we now have the funds necessary to continue our strong growth, but as always we are still very much focused on preserving and improving shareholder value with prudent spending,” he adds.

Volpara has also announced it is about to begin phase two of a major breast cancer research project [the PROCAS II project] with the UK National Health System.

“Having addressed all of phase one's data governance and system design requirements, Volpara will now deploy our solution across six sites, covering 8,000 women for a 22-month paid trial,” Highnam says.

Security flaw in Xiaomi electric scooters could have deadly consequences
An attacker could target a rider, and then cause the scooter to suddenly brake or accelerate.
Four ways the technology landscape will change in 2019
Until now, organisations have only spoken about innovative technologies somewhat theoretically. This has left people without a solid understanding of how they will ultimately manifest in our work and personal lives.
IDC: Top 10 trends for NZ’s digital transformation
The CDO title is declining, 40% of us will be working with bots, the Net Promoter Score will be key to success, and more.
Kiwi partner named in HubSpot’s global top five
Hype & Dexter is an Auckland-based agency that specialises in providing organisations with marketing automation solutions.
Moustache Republic expands Aussie presence with new exec
The Kiwi digital commerce partner has appointed a Sydney-based director to oversee the expansion of the company’s Australian footprint.
Epson’s new EcoTank range with two years printing per tank
With 11 new EcoTank printers that give an average user two years of printing and cost just $17.99/colour to refill, Epson is ready to change the game.
Te reo Māori goes global via language app called Drops
If you’re keen to learn a few words of Māori – or as much as 90% of the language, you may want to check out an Android and iOS app called Drops.
Reckon Group announces a steady profit in 2018
Reckon continued its investment in growth throughout the year with a development spend of $14.3 million.